The use of laboratory-identified event surveillance to classify adverse outcomes due to Clostridioides difficile infection in Canadian long-term care facilities.
Ye ShenJennifer EllisonJenine LealKathryn R BushA Uma ChandranSumana FathimaJohn M ConlyPublished in: Infection control and hospital epidemiology (2020)
The prevalence of CDI adverse outcomes is in LTCFs was found to be high using LabID event surveillance. Annual review of CDI adverse outcomes using LabID event can minimize the burden of surveillance and standardize the process across all Alberta LTCFs.